Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 15

    Govt still mulling to bring medical devices under CDSCO: Minister tells parliament

    Govt still mulling to bring medical devices under CDSCO: Minister tells parliament

    Farhat Nasim20 Nov 2019 2:36 PM IST
    New Delhi: The NITI Aayog has not rejected the proposal to bring medical devices under the Central Drugs Standard Control Organisation (CDSCO), the...
    NCLAT rejects Dhanuka Labs Rs 1146 crore bid for Orchid Pharma for being less than Liquidation Value

    NCLAT rejects Dhanuka Labs Rs 1146 crore bid for Orchid Pharma for being less than Liquidation Value

    Medical Dialogues Bureau19 Nov 2019 12:36 PM IST
    New Delhi: The NCLAT has rejected the bid of Dhanuka Laboratories for the debt ridden Orchid Pharma, and vacated the order passed by the Chennai-bench...
    Pharmacists to protest at Jantar Mantar against amendment of Schedule K of Drugs and Cosmetics Act

    Pharmacists to protest at Jantar Mantar against amendment of Schedule K of Drugs and Cosmetics Act

    Farhat Nasim18 Nov 2019 2:55 PM IST
    New Delhi: The Indian Pharmacist Association (IPA) has decided to conduct a protest on November 29 at Jantar Mantar against the recent draft to amend...
    NPPA fixes retail price of 12 combo drugs including Aspirin, Atorvastatin, Metformin; Details

    NPPA fixes retail price of 12 combo drugs including Aspirin, Atorvastatin, Metformin; Details

    Farhat Nasim17 Nov 2019 1:08 PM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    You cannot discontinue critical medicines without Prior Notice: NPPA tells Abbott, Bayer Zydus Pharma, Sanofi

    You cannot discontinue critical medicines without Prior Notice: NPPA tells Abbott, Bayer Zydus Pharma, Sanofi

    Farhat Nasim16 Nov 2019 1:04 PM IST
    Abbott Healthcare has near monopoly (around 98% market share) for these critical medicines for leprosy, Bayer Zydus Pharma has about a 12% market...
    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    Medical Dialogues Bureau15 Nov 2019 4:29 PM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    NPPA Relief: Sun Pharma anti-cancer drug Gemcitabine gets price control exemption

    NPPA Relief: Sun Pharma anti-cancer drug Gemcitabine gets price control exemption

    Medical Dialogues Bureau14 Nov 2019 11:30 AM IST
    New Delhi: Through a recent order, the apex drug price regulator, National Pharmaceutical Pricing Authority (NPPA) has exempted drugmaker, Sun...
    NPPA fixes retail price of 14 drug formulations; Details

    NPPA fixes retail price of 14 drug formulations; Details

    Farhat Nasim13 Nov 2019 11:23 AM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Health Ministry proposes to allow Nurses, Community health workers to store, dispense medicines; Pharmacists see Red

    Health Ministry proposes to allow Nurses, Community health workers to store, dispense medicines; Pharmacists see Red

    Farhat Nasim12 Nov 2019 2:56 PM IST
    New Delhi: With the central government moving to permit many allied healthcare practitioners including Community Health Officers, Nurses, Auxiliary...
    USFDA nod to Reblozyl, Celgenes rare blood disorder drug

    USFDA nod to Reblozyl, Celgene's rare blood disorder drug

    Medical Dialogues Bureau11 Nov 2019 1:13 PM IST
    The U.S. Food and Drug Administration said on Friday it had approved treatment for a rare blood disorder from Celgene Corp, which is in the process of...
    Sun Pharma carried out off-label promotions of 3 drugs-Ilumya, Yonsa, Absorica, alleges former employee

    Sun Pharma carried out off-label promotions of 3 drugs-Ilumya, Yonsa, Absorica, alleges former employee

    Farhat Nasim10 Nov 2019 5:37 PM IST
    New Delhi: In a major setback to the country's largest drugmaker Sun Pharmaceuticals Ltd. (Sun Pharma), the firm has been accused of allegedly...
    Delhi Pharmaceutical Sciences and Research University collaborates with China Pharma University for free research

    Delhi Pharmaceutical Sciences and Research University collaborates with China Pharma University for free research

    Medical Dialogues Bureau10 Nov 2019 4:52 PM IST
    This MoU will enable free research collaboration with China Pharmaceutical University(CPU). It is also planned to have some unique postgraduate level...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok